Clinical Trial Update: Methylnaltrexone for Opioid-induced Constipation in Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating methylnaltrexone for opioid-induced constipation in cancer patients has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Constipation

Drugs mentioned

• RELISTOR (methylnaltrexone)

Snippet

Sponsor: University of Vermont | Conditions: Neoplasms, Constipation | Phase 2 | Status: COMPLETED | Results posted: 2016-02-02